|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 541 articles |
 Page 1 of 8 
|
RXi appoints Anastasia Khvorova as CSO.
October 27, 2008
Pfizer and UCB form UK joint venture to speed up drug discovery.
October 27, 2008
Neurotech opens new US facility in Rhode Island.
October 27, 2008
Amylin and Lilly enter supply agreement for Byetta once weekly.
October 27, 2008
ImmunoGen licenses TAP technology rights to Bayer.
October 27, 2008
Norgine appoints GSK's Stuart Dollow to senior position.
October 27, 2008
Vernalis shares up 10% as Serono returns anti-inflammatory drugs.
October 27, 2008
FDA approves new premixed formulation of Astellas' Vaprisol.
October 27, 2008
Promising Ph II data for Genzyme/Bayer's alemtuzumab.(Clinical report)
October 27, 2008
Pfizer and Medivation collaboration clears review period.
October 27, 2008
Orchid Chemicals gets US approval for cefuroxime.
October 27, 2008
Picoplatin regimen cuts PSA by half in 78% of HRPC patients; Ph II stu...
October 27, 2008
Aires licenses NO prodrug from US NIH.
October 27, 2008
Bayer licenses Sartorius' UVivatec.
October 27, 2008
Promising Ph I data for Boehringer's early cancer drug.
October 27, 2008
FDA orphan status for children's cancer drug.
October 27, 2008
AstraZeneca files Seroquel for GAD in Europe.
October 27, 2008
Phoenix Biotech raises $3.6M, despite credit crunch.
October 27, 2008
Avantogen CEO joins Hawaii Biotech board.
October 27, 2008
Anadis gets go ahead for Ph IV BioGard trial.
October 27, 2008
Bend Research open to outside collaboration.
October 27, 2008
CLARIFICATION: Genzyme's Campath Ph II trial results.(Correction notic...
October 27, 2008
FDA delays decison on Forest/Cypress' milnacipran.
October 27, 2008
CVS completes tender offer for Longs Drug Stores.
October 27, 2008
US FDA approves Teva's fentanyl patch.
October 27, 2008
Nasdaq warns Genaera about low share price.
October 27, 2008
Mozambique ARV plant by 2010; illegal imports.
October 27, 2008
South Africa Ph II trial enrolls for TB vaccine.
October 27, 2008
US FDA grants J&J's Prezista expanded label.
October 27, 2008
Stock Commentary - Europe - week to Oct 20, 2008.
October 27, 2008
Stock Commentary - New York week to Oct 20, 2008.
October 27, 2008
Peregrine fully enrolled for Ph II NSCLC trial.
October 27, 2008
TorreyPines inititates dosing in Ph I pain trial.
October 27, 2008
Medivation presents prostate cancer data.
October 27, 2008
Cytochroma initiates Ph II trial of CTA018.
October 27, 2008
US federal govt assigns $1.6M for BiovaxID research.
October 27, 2008
Walgreen to acquire McKesson pharmacy unit.
October 27, 2008
American Oriental completes two buys.
October 27, 2008
Trius awarded $28M contract to develop novel antibiotics.
October 27, 2008
BIA welcomes UK Human stem cell law.
October 27, 2008
All-change for Novartis management in reshuffle.
October 27, 2008
Pfizer appoints Mace Rothenburg as SVP of oncology development.
October 27, 2008
Pervasis names Frederic Chereau as CEO.
October 27, 2008
Javelin names Novartis' Eric Lang as VP of clinical research.
October 27, 2008
Ferrosan names Ola Erici as chief executive.
October 27, 2008
Tibotec begins REALIZE trial enrollment.
October 27, 2008
AZ teams with US univ to fight depression.
October 27, 2008
Seattle Genetics reaches milestone in Progenics deal.
October 27, 2008
Ziopharm gets EU Orphan nod for palifosfamide.
October 27, 2008
Vit B does not slow AD cognitive decline.
October 27, 2008
Resveratrol could cut alcoholism liver damage.
October 27, 2008
Boehringer Ingleheim updates on pipeline; enters diabetes market for f...
October 27, 2008
EU information to patients directive stalls.
October 27, 2008
Novartis profit up 32% in 3rd qtr.(Financial report)
October 27, 2008
UK skills gap is reaching "tipping point" for drug R&D ABPI warns.
October 27, 2008
Pozen shares drop 28% on Treximet challenge.
October 27, 2008
UK HER2 patients miss out on best treatment.
October 27, 2008
Cell's Zevalin improves PFS in NHL patients.
October 27, 2008
Abraxane gains marketing OK in Australia.
October 27, 2008
Merck dedicates Durham, NC, vaccines plant.
October 27, 2008
Ph III Avastin gets interim DMC go-ahead.
October 27, 2008
Elan/Transition's Ph II AD study completes enrollment.(Clinical report...
October 27, 2008
S*BIO completes $26M series B financing.
October 27, 2008
France's LEEM signs disabled employment convention.
October 27, 2008
On-line pharmacy law clears US Congress.
October 27, 2008
Valeant completes retigabine deal with GSK.
October 27, 2008
Tranzyme to present ghrelin agonist data.
October 27, 2008
Celgene/Acceleron start Ph II MM trial of ACE-011.
October 27, 2008
UPDATE: EU information to patients directive stalls.
October 27, 2008
UPDATE: Roche[sup.1]s 9-month sales below expectations.
October 27, 2008
S-P profit falls 21%, still up on predictions.(Financial report)
October 27, 2008
Split over generic drug pricing in Japan; debate over remedies for low...
October 27, 2008
GSK's 3rd-qtr 2008 profit down 21.6% as generics lead to 13% US sales ...
October 27, 2008
UK GPs call for change in Big Pharma, including overhaul of sales oper...
October 27, 2008
US FTC closes, freezes assets of vast drug spam e-mail network.
October 27, 2008
|
1